Chennai Meenakshi Multispeciality Hospital Ltd
Established in 1979, Chennai Meenakshi Multispecialty Hospital Ltd. (Formerly known as Devaki Hospital Limited) is a 100-bedded hospital which is engaged in Health Care Services & Pharmacy.
- Market Cap ₹ 28.5 Cr.
- Current Price ₹ 38.2
- High / Low ₹ 54.6 / 18.5
- Stock P/E 106
- Book Value ₹ 0.24
- Dividend Yield 0.00 %
- ROCE 21.4 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 159 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 3.93% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
14.79 | 15.99 | 17.59 | 18.71 | 20.36 | 18.79 | 23.11 | 22.00 | 25.33 | 19.15 | 30.86 | 28.02 | 28.83 | |
12.51 | 13.20 | 15.21 | 16.57 | 17.34 | 17.49 | 19.30 | 19.89 | 22.88 | 18.51 | 25.12 | 24.99 | 26.56 | |
Operating Profit | 2.28 | 2.79 | 2.38 | 2.14 | 3.02 | 1.30 | 3.81 | 2.11 | 2.45 | 0.64 | 5.74 | 3.03 | 2.27 |
OPM % | 15.42% | 17.45% | 13.53% | 11.44% | 14.83% | 6.92% | 16.49% | 9.59% | 9.67% | 3.34% | 18.60% | 10.81% | 7.87% |
0.04 | 0.13 | 0.30 | -0.54 | 0.14 | 0.13 | 0.22 | 0.50 | 0.73 | 0.52 | 0.39 | 0.32 | 0.40 | |
Interest | 1.58 | 1.53 | 1.39 | 1.38 | 1.34 | 1.36 | 1.39 | 1.36 | 1.39 | 1.14 | 0.98 | 0.89 | 0.91 |
Depreciation | 0.67 | 0.71 | 0.81 | 1.19 | 1.16 | 1.12 | 1.15 | 1.20 | 1.24 | 1.27 | 1.17 | 1.18 | 1.16 |
Profit before tax | 0.07 | 0.68 | 0.48 | -0.97 | 0.66 | -1.05 | 1.49 | 0.05 | 0.55 | -1.25 | 3.98 | 1.28 | 0.60 |
Tax % | 0.00% | 0.00% | 8.33% | 0.00% | 0.00% | -0.95% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 30.47% | |
0.07 | 0.69 | 0.45 | -0.97 | 0.65 | -1.06 | 1.50 | 0.05 | 0.55 | -1.25 | 3.98 | 0.89 | 0.27 | |
EPS in Rs | 0.09 | 0.92 | 0.60 | -1.30 | 0.87 | -1.42 | 2.01 | 0.07 | 0.74 | -1.67 | 5.33 | 1.19 | 0.36 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 6% |
5 Years: | 4% |
3 Years: | 3% |
TTM: | 3% |
Compounded Profit Growth | |
---|---|
10 Years: | 3% |
5 Years: | -10% |
3 Years: | 18% |
TTM: | 23% |
Stock Price CAGR | |
---|---|
10 Years: | 21% |
5 Years: | 26% |
3 Years: | 62% |
1 Year: | 84% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 |
Reserves | -13.10 | -12.42 | -11.97 | -12.94 | -12.29 | -13.21 | -11.64 | -11.60 | -11.03 | -12.24 | -8.25 | -7.35 | -7.29 |
14.46 | 13.25 | 12.74 | 12.13 | 12.20 | 12.24 | 12.26 | 12.21 | 11.48 | 11.48 | 10.63 | 10.63 | 10.63 | |
6.45 | 8.99 | 10.98 | 12.05 | 11.09 | 11.84 | 11.26 | 11.11 | 11.53 | 12.49 | 11.54 | 11.74 | 11.73 | |
Total Liabilities | 15.28 | 17.29 | 19.22 | 18.71 | 18.47 | 18.34 | 19.35 | 19.19 | 19.45 | 19.20 | 21.39 | 22.49 | 22.54 |
12.39 | 13.83 | 15.11 | 15.27 | 14.51 | 14.01 | 14.53 | 14.07 | 13.86 | 12.87 | 14.08 | 13.94 | 0.00 | |
CWIP | 0.29 | 0.16 | 0.47 | 0.01 | 0.07 | 0.02 | 0.02 | 0.12 | 0.12 | 0.12 | 0.00 | 0.00 | 13.67 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
2.60 | 3.30 | 3.64 | 3.43 | 3.89 | 4.31 | 4.80 | 5.00 | 5.47 | 6.21 | 7.31 | 8.55 | 8.87 | |
Total Assets | 15.28 | 17.29 | 19.22 | 18.71 | 18.47 | 18.34 | 19.35 | 19.19 | 19.45 | 19.20 | 21.39 | 22.49 | 22.54 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1.76 | 5.12 | 4.32 | 4.00 | 1.74 | 2.61 | 2.20 | 2.31 | 2.99 | 3.30 | 3.97 | 2.95 | |
-0.69 | -2.27 | -2.30 | -1.78 | -0.23 | -0.47 | -1.61 | -0.81 | -0.95 | -0.14 | -2.21 | -0.91 | |
-1.03 | -2.74 | -1.91 | -2.00 | -1.41 | -1.32 | -1.37 | -1.41 | -2.12 | -0.98 | -1.62 | -0.75 | |
Net Cash Flow | 0.04 | 0.11 | 0.11 | 0.22 | 0.10 | 0.82 | -0.77 | 0.10 | -0.08 | 2.18 | 0.14 | 1.29 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 10.37 | 9.82 | 11.83 | 10.53 | 9.68 | 11.27 | 12.16 | 13.77 | 15.27 | 15.06 | 10.88 | 15.37 |
Inventory Days | 37.69 | 42.30 | 36.25 | 32.03 | 46.85 | 46.28 | 50.71 | 40.84 | 39.46 | 45.33 | 20.98 | 22.71 |
Days Payable | 158.70 | 126.91 | 112.88 | 108.01 | 80.41 | 87.33 | 88.28 | 80.39 | 66.15 | 117.24 | 105.93 | 109.87 |
Cash Conversion Cycle | -110.64 | -74.79 | -64.80 | -65.45 | -23.88 | -29.79 | -25.40 | -25.78 | -11.42 | -56.85 | -74.08 | -71.79 |
Working Capital Days | -105.63 | -140.61 | -157.70 | -173.04 | -130.69 | -164.14 | -111.51 | -113.48 | -95.83 | -170.78 | -81.73 | -91.71 |
ROCE % | 19.35% | 25.80% | 22.61% | 14.36% | 28.49% | 4.47% | 39.48% | 17.44% | 24.25% | -1.50% | 59.90% | 21.36% |
Documents
Announcements
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 13 Apr
- Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015, As Amended For The Year Ended March 31, 2024 11 Apr
- Certificate Under Regulation 40(9) Of SEBI (LODR) Reg. 2015 For The Year Ended March 31, 2024. 9 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Apr - The securities received for dematerialization have been mutilated and cancelled after due verification and the name of the depository has been substituted in our records …
- Disclosure Under Reg. 13(3) - Status Of Investor'S Complaints For The Period From 01.01.2024 To 31.03.2024 5 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Departments:[1]
a) Cardiology Department:
Company provides facilities for non-invasive evaluation of cardiac patients through ECG machine, Echocardiography machine and Treadmill machine.
b) Casualty Department:
This department is for Emergencies and trauma of all kinds
c) Diagnostic Services:
Services like Laboratories, C.T.SCAN and X-Ray machine, Ultrasonogram/ Echocardiography
d) Intensive Care Unit:
There is a well equipped 12-bedded IMCU / ICCU which is manned 24 hours for handling all forms of medical and cardiac emergencies.
e) Nephrology Department:
There is a separate department for Kidney related diseases
f) Physiotherapy Department